vs
ASTRONICS CORP（ATRO）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
ASTRONICS CORP的季度营收约是REPLIGEN CORP的1.2倍（$240.1M vs $197.9M），ASTRONICS CORP同比增速更快（15.1% vs 13.6%），REPLIGEN CORP自由现金流更多（$17.6M vs $15.8M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 13.9%）
Astronics Corporation是一家成立于1968年的美国航空航天电子企业，总部位于纽约州东奥罗拉，在纳斯达克上市，股票代码为ATRO。该公司专注于军用、商用及公务机的照明与电子系统集成业务，同时还提供半导体测试系统，在相关领域拥有较高知名度。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
ATRO vs RGEN — 直观对比
营收规模更大
ATRO
是对方的1.2倍
$197.9M
营收增速更快
ATRO
高出1.5%
13.6%
自由现金流更多
RGEN
多$1.7M
$15.8M
两年增速更快
RGEN
近两年复合增速
13.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $240.1M | $197.9M |
| 净利润 | — | $13.3M |
| 毛利率 | 33.3% | 52.5% |
| 营业利润率 | 14.8% | 9.0% |
| 净利率 | — | 6.7% |
| 营收同比 | 15.1% | 13.6% |
| 净利润同比 | — | 143.9% |
| 每股收益（稀释后） | $0.82 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ATRORGEN
| Q4 25 | $240.1M | $197.9M | ||
| Q3 25 | $211.4M | $188.8M | ||
| Q2 25 | $204.7M | $182.4M | ||
| Q1 25 | $205.9M | $169.2M | ||
| Q4 24 | $208.5M | $174.1M | ||
| Q3 24 | $203.7M | $154.9M | ||
| Q2 24 | $198.1M | $154.1M | ||
| Q1 24 | $185.1M | $151.3M |
净利润ATRORGEN
| Q4 25 | — | $13.3M | ||
| Q3 25 | $-11.1M | $14.9M | ||
| Q2 25 | $1.3M | $14.9M | ||
| Q1 25 | $9.5M | $5.8M | ||
| Q4 24 | — | $-30.3M | ||
| Q3 24 | $-11.7M | $-654.0K | ||
| Q2 24 | $1.5M | $3.3M | ||
| Q1 24 | $-3.2M | $2.1M |
毛利率ATRORGEN
| Q4 25 | 33.3% | 52.5% | ||
| Q3 25 | 30.5% | 53.2% | ||
| Q2 25 | 25.8% | 50.0% | ||
| Q1 25 | 29.5% | 53.6% | ||
| Q4 24 | 29.8% | 26.1% | ||
| Q3 24 | 27.1% | 50.0% | ||
| Q2 24 | 28.0% | 49.8% | ||
| Q1 24 | 25.7% | 49.5% |
营业利润率ATRORGEN
| Q4 25 | 14.8% | 9.0% | ||
| Q3 25 | 10.9% | 8.9% | ||
| Q2 25 | 2.3% | 7.6% | ||
| Q1 25 | 6.4% | 3.9% | ||
| Q4 24 | 4.3% | -17.7% | ||
| Q3 24 | 4.1% | -5.1% | ||
| Q2 24 | 3.8% | 1.0% | ||
| Q1 24 | 0.9% | 1.3% |
净利率ATRORGEN
| Q4 25 | — | 6.7% | ||
| Q3 25 | -5.2% | 7.9% | ||
| Q2 25 | 0.6% | 8.2% | ||
| Q1 25 | 4.6% | 3.4% | ||
| Q4 24 | — | -17.4% | ||
| Q3 24 | -5.8% | -0.4% | ||
| Q2 24 | 0.8% | 2.2% | ||
| Q1 24 | -1.7% | 1.4% |
每股收益（稀释后）ATRORGEN
| Q4 25 | $0.82 | $0.24 | ||
| Q3 25 | $-0.31 | $0.26 | ||
| Q2 25 | $0.04 | $0.26 | ||
| Q1 25 | $0.26 | $0.10 | ||
| Q4 24 | $-0.07 | $-0.55 | ||
| Q3 24 | $-0.34 | $-0.01 | ||
| Q2 24 | $0.04 | $0.06 | ||
| Q1 24 | $-0.09 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $18.2M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $140.1M | $2.1B |
| 总资产 | $706.7M | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资ATRORGEN
| Q4 25 | $18.2M | $767.6M | ||
| Q3 25 | $13.5M | $748.7M | ||
| Q2 25 | $13.5M | $708.9M | ||
| Q1 25 | $24.8M | $697.2M | ||
| Q4 24 | $9.3M | $757.4M | ||
| Q3 24 | $5.2M | $784.0M | ||
| Q2 24 | $2.9M | $809.1M | ||
| Q1 24 | $5.3M | $780.6M |
总债务ATRORGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ATRORGEN
| Q4 25 | $140.1M | $2.1B | ||
| Q3 25 | $108.9M | $2.1B | ||
| Q2 25 | $271.6M | $2.1B | ||
| Q1 25 | $266.8M | $2.0B | ||
| Q4 24 | $256.1M | $2.0B | ||
| Q3 24 | $249.2M | $2.0B | ||
| Q2 24 | $257.9M | $2.0B | ||
| Q1 24 | $251.7M | $2.0B |
总资产ATRORGEN
| Q4 25 | $706.7M | $2.9B | ||
| Q3 25 | $682.2M | $2.9B | ||
| Q2 25 | $646.7M | $2.9B | ||
| Q1 25 | $662.2M | $2.9B | ||
| Q4 24 | $648.8M | $2.8B | ||
| Q3 24 | $651.6M | $2.8B | ||
| Q2 24 | $644.9M | $2.9B | ||
| Q1 24 | $630.0M | $2.8B |
负债/权益比ATRORGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $27.6M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $15.8M | $17.6M |
| 自由现金流率自由现金流/营收 | 6.6% | 8.9% |
| 资本支出强度资本支出/营收 | 4.9% | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | $43.1M | $93.9M |
8季度趋势，按日历期对齐
经营现金流ATRORGEN
| Q4 25 | $27.6M | $25.7M | ||
| Q3 25 | $34.2M | $48.1M | ||
| Q2 25 | $-7.6M | $28.6M | ||
| Q1 25 | $20.6M | $15.0M | ||
| Q4 24 | $26.4M | $39.2M | ||
| Q3 24 | $8.4M | $49.3M | ||
| Q2 24 | $-6.3M | $42.2M | ||
| Q1 24 | $2.0M | $44.7M |
自由现金流ATRORGEN
| Q4 25 | $15.8M | $17.6M | ||
| Q3 25 | $21.0M | $43.4M | ||
| Q2 25 | $-12.2M | $21.5M | ||
| Q1 25 | $18.5M | $11.4M | ||
| Q4 24 | $23.2M | $33.6M | ||
| Q3 24 | $6.5M | $42.3M | ||
| Q2 24 | $-8.1M | $37.4M | ||
| Q1 24 | $439.0K | $36.4M |
自由现金流率ATRORGEN
| Q4 25 | 6.6% | 8.9% | ||
| Q3 25 | 9.9% | 23.0% | ||
| Q2 25 | -6.0% | 11.8% | ||
| Q1 25 | 9.0% | 6.8% | ||
| Q4 24 | 11.1% | 19.3% | ||
| Q3 24 | 3.2% | 27.3% | ||
| Q2 24 | -4.1% | 24.3% | ||
| Q1 24 | 0.2% | 24.0% |
资本支出强度ATRORGEN
| Q4 25 | 4.9% | 4.1% | ||
| Q3 25 | 6.2% | 2.5% | ||
| Q2 25 | 2.2% | 3.9% | ||
| Q1 25 | 1.0% | 2.1% | ||
| Q4 24 | 1.5% | 3.2% | ||
| Q3 24 | 0.9% | 4.5% | ||
| Q2 24 | 0.9% | 3.1% | ||
| Q1 24 | 0.9% | 5.5% |
现金转化率ATRORGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | — | 3.23× | ||
| Q2 25 | -5.81× | 1.92× | ||
| Q1 25 | 2.17× | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -4.08× | 12.70× | ||
| Q1 24 | — | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ATRO
| Product Line Electrical Power And Motion | $113.8M | 47% |
| Product Line Avionics | $32.0M | 13% |
| Military Aircraft | $28.0M | 12% |
| General Aviation | $22.3M | 9% |
| Government And Defense | $20.5M | 9% |
| Product Line Systems Certification | $13.2M | 6% |
| Product Line Structures | $3.7M | 2% |
| Product Line Other | $2.3M | 1% |
RGEN
暂无分部数据
